Embed Size (px)
Citation preview
Global Measles and Rubella UpdateNovember 2018
Measles
Number of Reported Measles Cases by WHO Regions
2018
RegionMember States*
Suspected cases
Measles cases
Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov DecDate
Received
AFR 42/47 44749 25494 12955 6897 5642 2998 4295 5058 3533 2547 1543 1564 1121 1399 1436 0 0 2018-11
AMR 32/35 24627 10342 0 0 10342 3 16 84 152 291 216 410 138 779 8253 0 0 2018-11
EMR 20/21 35676 19384 3975 6812 8597 2234 1744 2660 2710 3129 2245 2403 1157 996 106 0 0 2018-11
EUR 53/53 63873 54354 30579 2008 21767 5647 6589 7376 7658 8703 7037 5307 3611 2411 15 0 0 2018-11
SEAR 11/11 80556 61273 49884 8828 2561 7787 7600 12074 10789 10079 4786 2849 2983 2099 227 0 0 2018-11
WPR 26/27 52221 18545 10757 483 7305 1921 2478 3386 3232 2941 2098 1348 550 540 51 0 0 2018-11
Total 184/194 301702 189392 108150 25028 56214 20590 22722 30638 28074 27690 17925 13881 9560 8224 10088 0 0
2017
RegionMember States*
Suspected cases
Measles cases
Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov DecDate
Received
AFR 43/47 51565 24838 11007 8845 4986 3216 2896 3648 2370 2026 1859 1475 1412 1519 1695 1315 1407 2018-11
AMR 31/35 10886 895 0 0 895 1 8 19 13 5 0 0 1 1 0 0 847 2018-11
EMR 20/21 36139 12777 1918 693 10166 1103 1080 1296 1280 1460 1057 1061 812 706 941 950 1031 2018-11
EUR 53/53 31134 24592 4427 6059 14106 1422 1873 3004 2885 2921 2572 1380 868 965 1327 2352 3023 2018-11
SEAR 11/11 99722 79368 56164 17492 5712 8572 9758 13139 10343 7564 4627 3888 4412 3846 3167 5011 5041 2018-11
WPR 26/27 53130 10296 2692 107 7497 778 894 1501 1222 1120 800 772 700 725 770 617 397 2018-11
Total 184/194 282576 152766 76208 33196 43362 15092 16509 22607 18113 15096 10915 8576 8205 7762 7900 10245 11746
Notes: Based on data received 2018-11 - This is surveillance data, hence for the last month, the data may be incomplete. * Member States
Reporting / Total Member States in Region
2018
RegionMember States*
Suspected cases
Measles cases
Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov DecDate
Received
AFR 42/47 44749 25494 12955 6897 5642 2998 4295 5058 3533 2547 1543 1564 1121 1399 1436 0 0 2018-11
AMR 32/35 24627 10342 0 0 10342 3 16 84 152 291 216 410 138 779 8253 0 0 2018-11
EMR 20/21 35676 19384 3975 6812 8597 2234 1744 2660 2710 3129 2245 2403 1157 996 106 0 0 2018-11
EUR 53/53 63873 54354 30579 2008 21767 5647 6589 7376 7658 8703 7037 5307 3611 2411 15 0 0 2018-11
SEAR 11/11 80556 61273 49884 8828 2561 7787 7600 12074 10789 10079 4786 2849 2983 2099 227 0 0 2018-11
WPR 26/27 52221 18545 10757 483 7305 1921 2478 3386 3232 2941 2098 1348 550 540 51 0 0 2018-11
Total 184/194 301702 189392 108150 25028 56214 20590 22722 30638 28074 27690 17925 13881 9560 8224 10088 0 0
Number of Reported Measles Cases by WHO Regions
Notes: Based on data received 2018-11 and 2017-11 - This is surveillance data, hence for the last month, the data may be incomplete. *
Member States Reporting / Total Member States in Region
2017
RegionMember States*
Suspected cases
Measles cases
Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov DecDate
Received
AFR 43/47 38479 17856 8587 5248 4021 3037 2674 3228 1893 1704 1383 929 1021 1173 814 0 0 2017-11
AMR 30/35 8658 224 0 0 224 1 8 19 13 5 1 3 29 24 121 0 0 2017-11
EMR 20/21 26933 8585 210 665 7710 1093 918 969 1584 1676 899 730 460 234 22 0 0 2017-11
EUR 52/53 17256 13713 2499 3485 7729 1092 1850 2919 1708 1869 1492 1281 807 691 4 0 0 2017-11
SEAR 11/11 71098 55940 42574 8200 5166 7344 8621 12151 9474 6884 3849 2803 3165 1506 143 0 0 2017-11
WPR 26/27 37444 8657 2533 74 6050 639 823 1461 1295 1174 846 784 803 832 0 0 0 2017-11
Total 182/194 199868 104975 56403 17672 30900 13206 14894 20747 15967 13312 8470 6530 6285 4460 1104 0 0
Measles case distribution by month and WHO Region (2014-2018)
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
0
5000
10000
15000
20000
25000
30000
35000
40000
Month of onset
Mea
sles
cas
es
(Lab
+Ep
i+C
linic
al)
WPRSEAREUREMRAMRAFR
Notes: Based on data received 2018-11 - Data Source: IVB Database - This is surveillance data, hence for the last month(s), the data may be
incomplete.
The clustering of cases in AMR at specific time points is an artifact of reporting
Measles Incidence Rate per Million(12M period)
Top 10**
Country Cases Rate
India 66794 50.44
Ukraine 34218 770.01
Philippines 12243 118.50
Yemen 9499 344.36
Nigeria 7299 39.24
Serbia 5725 649.09
China 4200 2.99
Pakistan 3721 19.26
DR Congo 3672 46.64
Indonesia 3476 13.31
Other countries with
high incidence rates***
Country Cases Rate
Albania 1396 477.05
Liberia 1902 412.24
Georgia 1471 374.74
Montenegro 203 322.93
Greece 3032 271.11
Lebanon 907 151.00
Notes: Based on data received 2018-11 and covering the period between 2017-10 and 2018-09 - Incidence: Number of cases / population* *
100,000 - * World population prospects, 2017 revision - ** Countries with the highest number of cases for the period - *** Countries with the
highest incidence rates (excluding those already listed in the table above)
Measles cases from countries with known discrepancies between case-based and aggregate surveillance, as reported by country
Country Year Cases Data Source
DR Congo 2017 45165 SITUATION EPIDEMIOLOGIQUE DE LA ROUGEOLE EN RDC, Week of 6/11/20182018 39496
Somalia 2017 23394 Somali EPI/POL Weekly Update Week 43
2018 8097
Disclaimer
This document contains data provided to WHO by member states. Note that some member states only
provide aggregate data to WHO, and for these, we are unable to generate a country profile. Some
member states report all cases at one time point for the entire year, and thus epidemiologic curves
generated are not accurate and a reporting artifact. For some countries, cases are reported by age
category, not by exact age in months and/or years. Thus, age distribution/incidence is approximate.
Cases classified as pending by countries are classified at WHO as clinically compatible at this time, and
thus numbers might different between data shown here and provided by the member state or WHO
country/regional offices.
*UN population data is used as the denominator for calculating incidence.
Measles case distribution (AFR), 2014-2018
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
0
2000
4000
6000
8000
Month of onset
Nu
mb
er o
f m
eas
les
case
s
Uganda
OthersNigeriaNiger
LiberiaGabon
EthiopiaEquatorial GuineaDR Congo
CameroonAngola
Notes: Based on data received 2018-11 - Data Source: IVB Database
DRC has experienced a nationwide epidemic that has affected all Provinces, however, only a small proportion of the measles cases in the IDSR
aggregate reporting system are reflected in the case based data. As of 27 May 2013, South Sudan has reassigned to the Africa region (AFR)
from the Eastern Mediterranean region (EMR). For data presentation and statistical purposes, South Sudan data is presented in AFR for all the
years.
Measles cases: Chad
0
100
200
300
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
Sub-national (9-59 M)
Cov: 112.4%Sub-national (9-59 M)
National SIA Sub-national SIA
0
50
100
150
200
250
300
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Chad age distribution, vaccination status, and incidence, 2017-10 to 2018-09
0
50
100
150
Inci
den
ce r
ate
per
1,0
00
,00
0
111.8132.1
69.154.7
39.8 31.810.4
YearConfirmed
Cases
2006 15
2007 65
2008 70
2009 632
2010 219
2011 156
2012 153
2013 217
2014 1251
2015 418
2016 168
2017 26
2018 814
Measles cases: Democratic Republic of the Congo
0
1000
2000
3000
40002
01
6-1
0
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
Sub-national (6-59 M)
Cov: 103.5%
National SIA Sub-national SIA
0
500
1000
1500
2000
2500
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Democratic Republic of the Congo age distribution, vaccination status, and incidence, 2017-10 to 2018-09
0
50
100
150
200
Inci
den
ce r
ate
per
1,0
00
,00
0
151.7
188.8
69
13.4 4.6 2.4 0.4
YearConfirmed
Cases
2006 1012
2007 539
2008 214
2009 83
2010 208
2011 1651
2012 2332
2013 2527
2014 1649
2015 5029
2016 4932
2017 3621
2018 3445
Measles cases: Ethiopia
0
200
400
600
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
Sub-national (9 M-14 Y)
Cov: 96.3%
Sub-national (6-179 M)
Cov: 98%
National SIA Sub-national SIA
0
100
200
300
400
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Ethiopia age distribution, vaccination status, and incidence, 2017-10 to 2018-09
0
10
20
Inci
den
ce r
ate
per
1,0
00
,00
0
23.1 24.5
17
11.9
17.9
6.1
0.5
YearConfirmed
Cases
2006 1278
2007 1472
2008 3161
2009 2642
2010 6205
2011 3552
2012 4616
2013 6137
2014 14282
2015 17778
2016 4568
2017 1912
2018 967
Measles cases: Kenya
0
50
100
1502
01
6-1
0
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
20
40
60
80
100
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Kenya age distribution, vaccination status, and incidence, 2017-10 to 2018-09
0
10
20
Inci
den
ce r
ate
per
1,0
00
,00
0
17.4
14.1
6.6
3 3.81.8
0.6
YearConfirmed
Cases
2006 2350
2007 486
2008 34
2009 65
2010 105
2011 2462
2012 2380
2013 243
2014 390
2015 112
2016 124
2017 63
2018 374
Measles cases: Madagascar
0
200
400
600
800
10002
01
6-1
0
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
10
20
30
40
50
60
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Madagascar age distribution, vaccination status, and incidence, 2017-10 to 2018-09
0
10
20
Inci
den
ce r
ate
per
1,0
00
,00
0
18.7
14.516.5
12.3
3.42.1
0.7
YearConfirmed
Cases
2006 2
2007 0
2008 12
2009 2
2010 1
2011 1
2012 3
2013 7
2014 1
2015 6
2016 17
2017 84
2018 974
Measles cases: Nigeria
0
1000
2000
30002
01
6-1
0
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
Sub-national (6 M-10 Y) NA (9-59 M)
National SIA Sub-national SIA
0
2000
4000
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Nigeria age distribution, vaccination status, and incidence, 2017-10 to 2018-09
0
50
100
150
Inci
den
ce r
ate
per
1,0
00
,00
0
123.7
149.7
65.7
247.9 5.2 2.3
YearConfirmed
Cases
2006 1019
2007 3129
2008 10453
2009 1498
2010 9072
2011 19062
2012 6423
2013 55392
2014 6850
2015 12391
2016 17581
2017 11188
2018 6404
Measles cases: Uganda
0
100
200
300
400
500
6002
01
6-1
0
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
500
1000
1500
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Uganda age distribution, vaccination status, and incidence, 2017-10 to 2018-09
0
50
100
150
200
250
Inci
den
ce r
ate
per
1,0
00
,00
0
224.4 220.5
106.5
51.817.9 4.5 1.9
YearConfirmed
Cases
2006 1035
2007 291
2008 115
2009 86
2010 41
2011 132
2012 720
2013 460
2014 315
2015 466
2016 252
2017 892
2018 2311
Measles case distribution (AMR), 2014-2018
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
5500
6000
6500
7000
7500
8000
8500
9000
Month of onset
Nu
mb
er o
f m
eas
les
case
s
Venezuela (Bolivarian Republic of)
USAPeruOthersMexicoEcuador
ColombiaChileCanadaBrazilArgentina
Notes: Based on data received 2018-11 - Data Source: IVB Database
The clustering of cases at specific time points is an artifact of reporting
Measles cases: Brazil
0
2000
4000
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
YearConfirmed
Cases
2008 0
2009 0
2010 68
2012 2
2013 192
2014 708
2015 214
2016 0
2017 0
2018 4299
Measles cases: Venezuela (Bolivarian Republic of)
0
2000
4000
60002
01
6-1
0
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
500
1000
1500
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Venezuela (Bolivarian Republic of) age distribution, vaccination status, and incidence, 2017-10 to 2018-09
0
500
1000
1500
Inci
den
ce r
ate
per
1,0
00
,00
0
1541.4
546
150.5 106.6 29.9 11.8 5.5
YearConfirmed
Cases
2008 0
2009 0
2010 0
2011 0
2012 1
2013 0
2014 0
2015 0
2016 0
2017 727
2018 5525
The clustering of cases at specific time points is an artifact of reporting
Measles case distribution (EMR), 2014-2018
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
0
500
1000
1500
2000
2500
3000
Month of onset
Nu
mb
er o
f m
eas
les
case
s
YemenUnited Arab EmiratesSyrian Arab Republic
SudanSomaliaSaudi Arabia
PakistanOthersIraqEgyptAfghanistan
Notes: Based on data received 2018-11 - Data Source: IVB Database
Measles cases: Libya
0
100
200
300
4002
01
6-1
0
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
50
100
150
200
250
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Libya age distribution, vaccination status, and incidence, 2017-10 to 2018-09
0
500
1000
1500
Inci
den
ce r
ate
per
1,0
00
,00
0
1455.6
390.4
115.5 76.6 32 33.6 14.5
YearConfirmed
Cases
2006 38
2007 59
2008 8
2009 329
2010 54
2011 126
2012 325
2013 164
2014 176
2015 87
2016 28
2017 3
2018 622
Measles cases: Sudan
0
200
400
600
800
10002
01
6-1
0
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
500
1000
1500
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Sudan age distribution, vaccination status, and incidence, 2017-10 to 2018-09
0
100
200
300
400
500
Inci
den
ce r
ate
per
1,0
00
,00
0
454.4
270.6
71.232.8 38.4 31.7 4.9
YearConfirmed
Cases
2006 274
2007 483
2008 97
2009 68
2010 613
2011 5616
2012 8521
2013 2811
2014 676
2015 3585
2016 1767
2017 665
2018 2929
Measles cases: Pakistan
0
500
1000
1500
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
500
1000
1500
2000
2500
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Pakistan age distribution, vaccination status, and incidence, 2017-10 to 2018-09
0
50
100
150
Inci
den
ce r
ate
per
1,0
00
,00
0
157.6
105.9
27.55.2 0.8 0.4 0
YearConfirmed
Cases
2006 35
2007 33
2008 53
2009 472
2010 1111
2011 2676
2012 8048
2013 8030
2014 1370
2015 1117
2016 2806
2017 6780
2018 2358
Measles cases: Yemen
0
500
1000
1500
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
2000
4000
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Yemen age distribution, vaccination status, and incidence, 2017-10 to 2018-09
0
500
1000
1500
2000
Inci
den
ce r
ate
per
1,0
00
,00
0
1916.4
1525.7
611.7
143.4 36.1 45.9 8.1
YearConfirmed
Cases
2006 4989
2007 50
2008 53
2009 127
2010 372
2011 847
2012 2143
2013 571
2014 817
2015 465
2016 143
2017 2101
2018 8742
Measles case distribution (EUR), 2014-2018
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
Month of onset
Nu
mb
er o
f m
eas
les
case
s
UkraineSerbiaRussian FederationRomaniaOthersKyrgyzstan
ItalyGermanyGeorgia
FranceBosnia and Herzegovina
Notes: Based on data received 2018-11 - Data Source: IVB Database
Measles cases: Israel
0
100
2002
01
6-1
1
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
50
100
150
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Israel age distribution, vaccination status, and incidence, 2017-10 to 2018-09
0
100
200
300
400
Inci
den
ce r
ate
per
1,0
00
,00
0
378.8
226.9166.1
65.532.6 29.9 18.9
YearConfirmed
Cases
2006 8
2007 539
2008 891
2009 5
2010 19
2011 46
2012 149
2013 57
2014 3
2015 80
2016 10
2017 16
2018 526
Measles cases: Ukraine
0
2000
4000
60002
01
6-1
0
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
2000
4000
6000
8000
<1 year 1-4 years 5-9 years 10-14 years 15-19 years 20-29 years 30+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Ukraine age distribution, vaccination status, and incidence, 2017-10 to 2018-09
0
1000
2000
3000
4000
Inci
den
ce r
ate
per
1,0
00
,00
0
3981.3
2950.6 2768.52239.1
773.3 543.4272.9
YearConfirmed
Cases
2006 945
2007 232
2008 41
2009 24
2010 42
2011 1313
2012 12744
2013 3308
2014 2326
2015 141
2016 90
2017 4782
2018 31312
Measles case distribution (SEAR (excl. India)), 2014-2018
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
0
500
1000
1500
2000
2500
3000
3500
Month of onset
Nu
mb
er o
f m
eas
les
case
s
Timor-LesteThailandSri LankaNepalMyanmar
MaldivesIndonesiaDPR KoreaBhutanBangladesh
Notes: Based on data received 2018-11 - Data Source: IVB Database
Measles cases: Indonesia
0
2000
4000
60002
01
6-1
0
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
Sub-national (9 M-15 Y)
Cov: 100.5%
National SIA Sub-national SIA
0
100
200
300
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Indonesia age distribution, vaccination status, and incidence, 2017-10 to 2018-09
0
10
20
Inci
den
ce r
ate
per
1,0
00
,00
0
17.915.1
13.8
9
4.5
0.9 0.2
YearConfirmed
Cases
2006 21911
2007 20837
2008 16417
2009 21008
2010 23471
2011 23510
2012 16786
2013 10093
2014 9498
2015 6209
2016 7204
2017 11389
2018 2374
Measles case distribution (SEAR, India), 2014-2018
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
0
5000
10000
15000
Month of onset
Nu
mb
er o
f m
eas
les
case
s
India
Notes: Based on data received 2018-11 - Data Source: IVB Database
Measles cases: India
0
10000
20000
300002
01
6-1
0
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
Rollover-Nat (9 M-15 Y)
National SIA Sub-national SIA
0
2000
4000
6000
8000
10000
12000
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
India age distribution, vaccination status, and incidence, 2017-10 to 2018-09
0
20
40
60
80
100
Inci
den
ce r
ate
per
1,0
00
,00
0
98.391.5
77.5
21.5
4.5 1.4 0.2
YearConfirmed
Cases
2014 80306
2015 83026
2016 70798
2017 60468
2018 55399
Measles cases: Thailand
0
100
200
300
4002
01
6-1
0
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
100
200
300
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Thailand age distribution, vaccination status, and incidence, 2017-10 to 2018-09
0
50
100
150
200
250
Inci
den
ce r
ate
per
1,0
00
,00
0
209.2
77.6
27.5 14.8 25.9 20.70.8
YearConfirmed
Cases
2006 3962
2007 3517
2008 6339
2009 5272
2010 2273
2011 2873
2012 4072
2013 2056
2014 834
2015 190
2016 1009
2017 2032
2018 960
Measles case distribution (WPR), 2014-2018
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
0
2000
4000
6000
8000
10000
12000
14000
16000
18000
20000
22000
Month of onset
Nu
mb
er o
f m
eas
les
case
s
Viet NamSingaporeRepublic of KoreaPhilippinesPapua New Guinea
Others
MongoliaMalaysiaJapan
ChinaAustralia
Notes: Based on data received 2018-11 - Data Source: IVB Database
Distribution of measles genotypes(last 12 months)
Notes: Data Source: MeaNS database (Genotypes) and IVB Database (Incidence) as of 2018-11-08 and covering the period 2017-10-01 to
2018-09-30 - Pie charts proportional to the number of sequenced viruses
Rubella
Number of Reported Rubella Cases by WHO Regions
2018
RegionMember States*
Rubella cases
Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov DecDate
Received
AFR 42/47 2774 0 0 2774 337 362 562 357 352 253 236 196 101 18 0 0 2018-11
AMR 26/35 2 0 0 2 0 1 0 1 0 0 0 0 0 0 0 0 2018-11
EMR 20/21 928 111 48 769 104 116 160 128 131 92 111 75 10 1 0 0 2018-11
EUR 36/53 704 620 6 78 82 96 75 96 92 78 63 76 46 0 0 0 2018-11
SEAR 11/11 2245 0 557 1688 297 411 543 332 342 147 49 74 34 16 0 0 2018-11
WPR 15/27 2846 159 47 2640 113 104 290 507 750 337 252 226 266 1 0 0 2018-11
Total 150/194 9499 890 658 7951 933 1090 1630 1421 1667 907 711 647 457 36 0 0
2017
RegionMember States*
Rubella cases
Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov DecDate
Received
AFR 42/47 4569 0 0 4569 278 515 586 328 343 372 212 331 388 647 459 110 2018-11
AMR 26/35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2018-11
EMR 20/21 914 43 1 870 76 111 121 106 156 112 49 22 25 50 47 39 2018-11
EUR 30/53 703 570 17 116 59 60 87 69 85 58 54 47 38 54 46 46 2018-11
SEAR 11/11 7570 0 2080 5490 614 1092 1519 1132 810 361 329 511 345 367 256 234 2018-11
WPR 14/27 2287 258 162 1867 154 201 342 307 295 194 195 128 115 81 110 165 2018-11
Total 143/194 16043 871 2260 12912 1181 1979 2655 1942 1689 1097 839 1039 911 1199 918 594
Notes: Based on data received 2018-11 - This is surveillance data, hence for the last month, the data may be incomplete. * Member States
Reporting / Total Member States in Region
Rubella Case Distribution by Month and WHO Region (2015-2018)
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
5500
Month of onset
Ru
bel
la c
ases
(La
b+E
pi+
Clin
ical
)
WPRSEAREUREMRAMRAFR
Notes: Based on data received 2018-11 - Data Source: IVB Database - This is surveillance data, hence for the last month(s), the
data may be incomplete.
Rubella cases: AFR
0
200
400
6002
01
6-1
0
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
Not introduced in EPIIntroduced <5 years ago (after 2012)
Introduced >=5 years ago (2012 and before)
Month of onset
Nu
mb
er
of
case
s(I
gM+
on
ly)
AFR Rubella Case Distribution (November 2016-October 2018)
0
200
400
600
0 1 2 3 4 5 6 7 8 91
01
11
21
31
41
51
61
71
81
92
02
12
22
32
42
52
62
72
82
93
03
13
23
33
43
53
63
73
83
94
04
14
24
34
44
54
6
Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017
Age at onset (in years)
Nu
mb
er o
f ca
ses
(IgM
+ o
nly
)
AFR Age distribution of Rubella IgM+ cases by vaccine introduction status in the National EPI Programme (November 2017-October 2018)
Top 10 countries (last 12 M)
labelRCV in
RICases
% of Total
Ethiopia No 692 21
South Africa No 616 18
Nigeria No 454 14
Others - 386 12
DR Congo No 379 11
Uganda No 307 9
Cote d'Ivoire No 171 5
Mali No 95 3
Congo No 94 3
Mozambique No 90 3
Liberia No 59 2
Notes: Based on data received 2018-11 Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31
Dec 2016.
Rubella cases: EMR
0
50
100
1502
01
6-1
0
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
Not introduced in EPIIntroduced <5 years ago (after 2012)
Introduced >=5 years ago (2012 and before)
Month of onset
Nu
mb
er
of
case
s(l
ab +
ep
i-lin
ked
+ c
linic
al)
EMR Rubella Case Distribution (November 2016-October 2018)
0
50
100
0 1 2 3 4 5 6 7 8 91
01
11
21
31
41
51
61
71
81
92
02
12
22
32
42
52
62
72
82
93
03
13
23
33
43
53
63
73
83
94
04
14
24
34
44
54
6
Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017
Age at onset (in years)
Nu
mb
er o
f ca
ses
(lab
+ e
pi-
linke
d +
clin
ical
) EMR Age distribution of Rubella cases by vaccine introduction status in the National EPI Programme (November 2017-October 2018)
Top 10 countries (last 12 M)
labelRCV in
RICases
% of Total
Sudan No 317 31
Yemen 2015 309 30
Pakistan No 199 20
Afghanistan No 42 4
Saudi Arabia 1991 35 3
Iran (Islamic Republic of)
2004 34 3
Others - 31 3
Tunisia 2004 20 2
United Arab Emirates
1985 10 1
Iraq 1995 9 1
Libya 1995 8 1
Notes: Based on data received 2018-11 Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31
Dec 2016.
Rubella cases: EUR
0
20
40
60
80
1002
01
6-1
0
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
Not introduced in EPIIntroduced <5 years ago (after 2012)
Introduced >=5 years ago (2012 and before)
Month of onset
Nu
mb
er
of
case
s(l
ab +
ep
i-lin
ked
+ c
linic
al)
EUR Rubella Case Distribution (November 2016-October 2018)
0
100
200
0 1 2 3 4 5 6 7 8 91
01
11
21
31
41
51
61
71
81
92
02
12
22
32
42
52
62
72
82
93
03
13
23
33
43
53
63
73
83
94
04
14
24
34
44
54
6
Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017
Age at onset (in years)
Nu
mb
er o
f ca
ses
(lab
+ e
pi-
linke
d +
clin
ical
) EUR Age distribution of Rubella cases by vaccine introduction status in the National EPI Programme (November 2017-October 2018)
Top 10 countries (last 12 M)
labelRCV in
RICases
% of Total
Poland 1988 438 55
Ukraine 2001 201 25
Germany 1991 54 7
Others - 24 3
Italy 1972 23 3
Austria 1973 18 2
Turkey 2006 12 2
Kyrgyzstan 2001 10 1
Romania 2002 6 1
Ireland 1971 5 1
Portugal 1984 5 1
Notes: Based on data received 2018-11 Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31
Dec 2016. Spikes in age-distribution curve are an artifact of reporting by age bands ( 0=<1 yrs, 2=1-4 yrs, 7=5-9 yrs, 12=10-14 yrs, 17=15-19
yrs, 25=20-29 yrs, 45=30+yrs) instead of by age from some member states.
Rubella cases: SEAR (excl. India)
0
200
400
6002
01
6-1
0
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
Not introduced in EPIIntroduced <5 years ago (after 2012)
Introduced >=5 years ago (2012 and before)
Month of onset
Nu
mb
er
of
case
s(l
ab +
ep
i-lin
ked
+ c
linic
al)
SEAR (excl. India) Rubella Case Distribution (November 2016-October 2018)
0
50
100
150
0 1 2 3 4 5 6 7 8 91
01
11
21
31
41
51
61
71
81
92
02
12
22
32
42
52
62
72
82
93
03
13
23
33
43
53
63
73
83
94
04
14
24
34
44
54
6
Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017
Age at onset (in years)
Nu
mb
er o
f ca
ses
(lab
+ e
pi-
linke
d +
clin
ical
) SEAR (excl. India) Age distribution of Rubella cases by vaccine introduction status in the National EPI Programme (November 2017-October 2018)
Top 10 countries (last 12 M)
labelRCV in
RICases
% of Total
Indonesia No 1171 77
Bangladesh 2012 291 19
Nepal 2013 34 2
Thailand 1993 11 1
Myanmar 2015 10 1
Timor-Leste 2016 5 0
Bhutan 2006 2 0
Notes: Based on data received 2018-11 Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31
Dec 2016.
Rubella cases: Bangladesh
0
20
40
602
01
6-1
0
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
ClinicalEpi
Lab
Month of onset
Nu
mb
er o
f ca
ses
SIA (9 M-<5 Y)
Cov: 101%
National SIA Sub-national SIA
0
20
40
60
80
100
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Bangladesh age distribution, vaccination status, and incidence, 2017-10 to 2018-09
0
5
10
15
20
Inci
den
ce r
ate
per
1,0
00
,00
0
19.4
6.54.3
2 1.4 0.4 0.2
YearConfirmed
Cases
2015 189
2016 165
2017 299
2018 264
Rubella cases: India
0
200
400
600
800
10002
01
6-1
0
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
ClinicalEpi
Lab
Month of onset
Nu
mb
er o
f ca
ses
SIA (9 M-15 Y)
National SIA Sub-national SIA
0
100
200
300
400
500
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
India age distribution, vaccination status, and incidence, 2017-10 to 2018-09
0
1
2
3
4
Inci
den
ce r
ate
per
1,0
00
,00
0
2.9 2.7
3.4
2.2
0.4 0.2 0
YearConfirmed
Cases
2015 3265
2016 9084
2017 2854
2018 1066
Rubella cases: Indonesia
0
200
400
600
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
ClinicalEpi
Lab
Month of onset
Nu
mb
er o
f ca
ses
SIA (9 M-15 Y)
Cov: 100.5%
National SIA Sub-national SIA
0
100
200
300
400
500
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Indonesia age distribution, vaccination status, and incidence, 2017-10 to 2018-09
0
5
10
15
20
Inci
den
ce r
ate
per
1,0
00
,00
0
13
9
19.6
15.5
5.9
20.4
YearConfirmed
Cases
2015 1379
2016 1170
2017 4349
2018 862
Rubella cases: WPR
0
200
400
600
8002
01
6-1
0
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
Not introduced in EPIIntroduced <5 years ago (after 2012)
Introduced >=5 years ago (2012 and before)
Month of onset
Nu
mb
er
of
case
s(l
ab +
ep
i-lin
ked
+ c
linic
al)
WPR Rubella Case Distribution (November 2016-October 2018)
0
50
100
0 1 2 3 4 5 6 7 8 91
01
11
21
31
41
51
61
71
81
92
02
12
22
32
42
52
62
72
82
93
03
13
23
33
43
53
63
73
83
94
04
14
24
34
44
54
6
Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017
Age at onset (in years)
Nu
mb
er o
f ca
ses
(lab
+ e
pi-
linke
d +
clin
ical
) WPR (Excl. China) Age distribution of Rubella cases by vaccine introduction status in the National EPI Programme (November 2017-October 2018)
Top 10 countries (last 12 M)
labelRCV in
RICases
% of Total
China 2008 2800 90
Malaysia 1998 133 4
Philippines 2010 82 3
Viet Nam 2015 42 1
Japan 1989 30 1
Singapore 1990 13 0
Lao People's Democratic
Republic2012 12 0
Cambodia 2013 3 0
Republic of Korea 1982 3 0
Mongolia 2009 2 0
Others - 1 0
Notes: Based on data received 2018-11 Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31
Dec 2016.
Rubella cases: China
0
200
400
600
8002
01
6-1
0
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
ClinicalEpi
Lab
Month of onset
Nu
mb
er o
f ca
ses
YearConfirmed
Cases
2014 11887
2015 8247
2016 4477
2017 1601
2018 2562
Rubella cases: Japan
0
5
10
152
01
6-1
1
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
20
18
-07
20
18
-08
20
18
-09
20
18
-10
20
18
-11
ClinicalEpi
Lab
Month of onset
Nu
mb
er o
f ca
ses
0
5
10
15
20
25
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Japan age distribution, vaccination status, and incidence, 2017-10 to 2018-09
0
0.5
1
Inci
den
ce r
ate
per
1,0
00
,00
0
0 0 0 0
0.2
0.9
0.1
YearConfirmed
Cases
2014 0
2015 2
2016 3
2017 5
2018 30
Japan is having a rubella outbreak but most cases are not reported to WHO
Distribution of rubella genotypes(last 12 months)
Notes: Data Source: RubNS database (Genotypes) and IVB Database (Incidence) as of 2018-11-08 and covering the period 2017-10-01 to
2018-09-30 - Pie charts proportional to the number of sequenced viruses
Laboratory
Measles and Rubella IgM Data Summary
2017
RegionMember States*
Specimens received
Measles tested
Measles positive n(%)
Measles equivocal n(%)
Measles negative n(%)
Rubella tested
Rubella positive n(%)
Rubella equivocal n(%)
Rubella negative n(%)
AFR 40/47 35163 35163 4629 (13) 664 (2) 29870 (85) 29591 4962 (17) 1260 (4) 23369 (79)
AMR 27/35 7796 7449 618 (8) 46 (1) 6179 (83) 6661 308 (5) 85 (1) 5683 (85)
EMR 20/21 36251 34782 10561 (30) 127 (0) 24094 (69) 32726 1105 (3) 99 (0) 31522 (96)
EUR 38/53 42450 37192 13748 (37) 272 (1) 22642 (61) 26322 434 (2) 66 (0) 25736 (98)
SEAR 11/11 35379 32335 13177 (41) 781 (2) 20062 (62) 20383 4831 (24) 741 (4) 14804 (73)
WPR 27/27 16467 15211 2100 (14) 333 (2) 11952 (79) 12656 606 (5) 418 (3) 10748 (85)
Total 163/194 173506 162132 44833 (28) 2223 (1) 114799 (71) 128339 12246 (10) 2669 (2) 111862 (87)
2018
RegionMember States*
Specimens received
Measles tested
Measles positive n(%)
Measles equivocal n(%)
Measles negative n(%)
Rubella tested
Rubella positive n(%)
Rubella equivocal n(%)
Rubella negative n(%)
AFR 38/47 27213 27213 5376 (20) 648 (2) 21189 (78) 20507 3189 (16) 1142 (6) 16176 (79)
AMR 29/35 9356 8120 972 (12) 65 (1) 6670 (82) 6445 277 (4) 159 (2) 5630 (87)
EMR 20/21 31047 26469 9312 (35) 153 (1) 17004 (64) 23418 1198 (5) 385 (2) 21835 (93)
EUR 37/53 45831 41700 14012 (34) 241 (1) 27171 (65) 25500 584 (2) 57 (0) 24838 (97)
SEAR 11/11 22191 17899 6541 (37) 453 (3) 10895 (61) 12139 1805 (15) 361 (3) 9969 (82)
WPR 27/27 26809 20574 3643 (18) 441 (2) 10962 (53) 16244 487 (3) 319 (2) 9161 (56)
Total 162/194 162447 141975 39856 (28) 2001 (1) 93891 (66) 104253 7540 (7) 2423 (2) 87609 (84)
Notes: Based on data received 2018-11 - * Member States Reporting / Total Member States in Region
Measles and Rubella IgM Data SummaryNotes: Based on data received 2018-11 - * Member States Reporting / Total Member States in Region
2017
RegionMember States*
Specimens received
Measles tested
Measles positive n(%)
Measles equivocal n(%)
Measles negative n(%)
Rubella tested
Rubella positive n(%)
Rubella equivocal n(%)
Rubella negative n(%)
AFR 37/47 26609 26609 3342 (13) 531 (2) 22736 (85) 22436 3562 (16) 912 (4) 17962 (80)
AMR 25/35 9646 9331 174 (2) 91 (1) 5692 (61) 8856 262 (3) 106 (1) 5523 (62)
EMR 20/21 27028 26227 7997 (30) 124 (0) 18106 (69) 24386 876 (4) 135 (1) 23375 (96)
EUR 37/53 30945 27219 11143 (41) 222 (1) 15492 (57) 18454 305 (2) 42 (0) 18042 (98)
SEAR 11/11 29452 26012 10970 (42) 553 (2) 14467 (56) 15971 3719 (23) 504 (3) 11743 (74)
WPR 27/27 12556 11686 1599 (14) 284 (2) 9792 (84) 9790 519 (5) 319 (3) 8875 (91)
Total 157/194 136236 127084 35225 (28) 1805 (1) 86285 (68) 99893 9243 (9) 2018 (2) 85520 (86)
Notes: Based on data received 2017-11 - * Member States Reporting / Total Member States in Region
2018
RegionMember States*
Specimens received
Measles tested
Measles positive n(%)
Measles equivocal n(%)
Measles negative n(%)
Rubella tested
Rubella positive n(%)
Rubella equivocal n(%)
Rubella negative n(%)
AFR 38/47 27213 27213 5376 (20) 648 (2) 21189 (78) 20507 3189 (16) 1142 (6) 16176 (79)
AMR 29/35 9356 8120 972 (12) 65 (1) 6670 (82) 6445 277 (4) 159 (2) 5630 (87)
EMR 20/21 31047 26469 9312 (35) 153 (1) 17004 (64) 23418 1198 (5) 385 (2) 21835 (93)
EUR 37/53 45831 41700 14012 (34) 241 (1) 27171 (65) 25500 584 (2) 57 (0) 24838 (97)
SEAR 11/11 22191 17899 6541 (37) 453 (3) 10895 (61) 12139 1805 (15) 361 (3) 9969 (82)
WPR 27/27 26809 20574 3643 (18) 441 (2) 10962 (53) 16244 487 (3) 319 (2) 9161 (56)
Total 162/194 162447 141975 39856 (28) 2001 (1) 93891 (66) 104253 7540 (7) 2423 (2) 87609 (84)
Performance of Surveillance
Surveillance sensitivity reporting rate of measles and rubella (12 months, discarded cases* per 100,000 population)
Notes: Based on data received 2018-11 and covering the period between 2017-10 and 2018-09 - Target: >= 2 discarded cases* / 100,000
population** - * Suspected cases investigated and discarded as non-measles non-rubella using laboratory testing and/or epidemiological linkage
to another etiology ** World population prospects, 2017 revision
Supplementary Immunization Activities
Link to global Measles SurveillanceHQ website
• AFR Monthly feedback tables
• AMR: Weekly bulletin (published every Friday)
• EMR: Home page
• EUR : Periodical bulletin
Monthly data
• SEAR: Monthly bulletin
EPI country fact sheets
• WPR: Monthly Bulletin
Country profiles
(Switch to presentation mode if links are inactive)
Regional Bulletins and Newsletters
![NERCTranslate this pagePDF-1.6 %âãÏÓ 185 0 obj > endobj 224 0 obj >/Filter/FlateDecode/ID[5F80D396FBBD2C4A8EC49E508690C59E>464D8FC4845BE345BACF97CEA86A1E89>]/Index[185 568]/Info](https://img.pdfslide.us/doc/110x75/5ac3a7e67f8b9aa0518c9416/nerctranslate-this-pdf-16-185-0-obj-endobj-224-0-obj-filterflatedecodeid5f80d396fbbd2c4a8ec49e508690c59e464d8fc4845be345bacf97cea86a1e89index185.jpg)
![From: Montie Young [montieyoung@ev1.net] Jonathan G ...Allard, Wayne CO R 224-5941 224-6471 Campbell, Ben Nighthorse CO R 224-5852 228-4609 Dodd, Christopher J. CT D 224-2823 224-1083](https://img.pdfslide.us/doc/110x75/609bfa156780b67dff5623ee/from-montie-young-montieyoungev1net-jonathan-g-allard-wayne-co-r-224-5941.jpg)
